• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

游离前列腺特异性抗原(PSA)水平百分比对低PSA水平筛查人群中前列腺癌检出率的影响。

The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels.

作者信息

Pelzer Alexandre E, Volgger Hubert, Bektic Jasmin, Berger Andreas P, Rehder Peter, Bartsch Georg, Horninger Wolfgang

机构信息

Department of Urology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.

出版信息

BJU Int. 2005 Nov;96(7):995-8. doi: 10.1111/j.1464-410X.2005.05800.x.

DOI:10.1111/j.1464-410X.2005.05800.x
PMID:16225515
Abstract

OBJECTIVE

To evaluate the prostate cancer detection rate at low total prostate-specific antigen (tPSA) ranges of 2.6-4 and 4.1-10 ng/mL, according to different percentage free (f/t) PSA levels in a screening population.

SUBJECTS AND METHODS

In all, 1809 consecutive screening volunteers with a tPSA level of 2.6-10.0 ng/mL were assessed. Ten systematic ultrasonography-guided prostate biopsies and, since 2000, an additional five Doppler-enhanced targeted biopsies were taken on the basis of age-specific tPSA reference ranges. We analysed the detection rate of prostate cancer according to f/tPSA ranges of 0-9%, 10-14%, 15-18% and >18%.

RESULTS

The detection rates for the subgroups with tPSA levels of 2.6-4.0 and 4.1-10.0 ng/mL were 20.2% and 27.0%, respectively. The cancer detection rate in the first group (2.6-4.0 ng/mL) at 0-10% fPSA was 22.9%, and that in the second group (4.1-10.0 ng/mL) at 0-10% was 36.9%. There were significant differences between these groups. If the f/tPSA was 10-15%, the cancer detection rate for the two groups were 22.6% and 32.5%, respectively (P < 0.05). There was no statistically significant difference in the cancer detecting rates at an f/tPSA of 15-18% or >18%.

CONCLUSION

There is a statistically significantly higher cancer detection rate when the f/tPSA is <15% than in groups of men with a f/tPSA of >15% in screening population assessed primarily using tPSA level.

摘要

目的

根据筛查人群中不同的游离(f/t)前列腺特异抗原水平,评估总前列腺特异抗原(tPSA)处于2.6 - 4 ng/mL和4.1 - 10 ng/mL低范围时的前列腺癌检出率。

对象与方法

共评估了1809名连续的筛查志愿者,其tPSA水平为2.6 - 10.0 ng/mL。根据年龄特异性tPSA参考范围进行了10次系统超声引导下前列腺穿刺活检,自2000年起还额外进行了5次多普勒增强靶向活检。我们根据f/tPSA范围为0 - 9%、10 - 14%、15 - 18%和>18%分析了前列腺癌的检出率。

结果

tPSA水平为2.6 - 4.0 ng/mL和4.1 - 10.0 ng/mL亚组的检出率分别为20.2%和27.0%。第一组(2.6 - 4.0 ng/mL)fPSA为0 - 10%时的癌症检出率为22.9%,第二组(4.1 - 10.0 ng/mL)fPSA为0 - 10%时为36.9%。这些组之间存在显著差异。如果f/tPSA为10 - 15%,两组的癌症检出率分别为22.6%和32.5%(P < 0.05)。f/tPSA为15 - 18%或>18%时的癌症检出率无统计学显著差异。

结论

在主要根据tPSA水平评估的筛查人群中,f/tPSA < 15%时的癌症检出率在统计学上显著高于f/tPSA > 15%的男性群体。

相似文献

1
The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels.游离前列腺特异性抗原(PSA)水平百分比对低PSA水平筛查人群中前列腺癌检出率的影响。
BJU Int. 2005 Nov;96(7):995-8. doi: 10.1111/j.1464-410X.2005.05800.x.
2
Prostate cancer detection in men with a 'normal' total prostate-specific antigen (PSA) level using percentage free PSA: a prospective screening study.使用游离前列腺特异性抗原百分比在总前列腺特异性抗原(PSA)水平“正常”的男性中检测前列腺癌:一项前瞻性筛查研究。
BJU Int. 2005 Jun;95(9):1249-52. doi: 10.1111/j.1464-410X.2005.05514.x.
3
Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.无症状且无前列腺癌临床证据的加拿大男性中前列腺特异性抗原的分布情况。
BJU Int. 2006 Jul;98(1):50-3. doi: 10.1111/j.1464-410X.2006.06193.x.
4
[The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].[中国男性不同前列腺特异性抗原(PSA)水平下前列腺癌的检出率]
Zhonghua Yi Xue Za Zhi. 2008 Jan 1;88(1):16-8.
5
Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.在无前列腺癌证据的当代筛查队列中前列腺特异性抗原(PSA)和游离PSA百分比的分布情况
BJU Int. 2007 Jul;100(1):37-41. doi: 10.1111/j.1464-410X.2007.06923.x. Epub 2007 May 4.
6
Percent free PSA as an additional measure in a prostate cancer screen.游离前列腺特异抗原百分比作为前列腺癌筛查的一项附加指标。
Clin Lab Sci. 2001 Spring;14(2):102-7.
7
[The usefulness of percentage of free prostate specific antigen/prostate specific antigen density in the diagnosis of prostate cancer].游离前列腺特异性抗原百分比/前列腺特异性抗原密度在前列腺癌诊断中的应用价值
Zhonghua Wai Ke Za Zhi. 2006 Mar 15;44(6):379-81.
8
Incidental acute prostatic inflammation is associated with a lower percentage of free prostate-specific antigen than other benign conditions of the prostate: a prospective screening study.偶发性急性前列腺炎与游离前列腺特异性抗原的比例低于前列腺其他良性疾病相关:一项前瞻性筛查研究。
BJU Int. 2006 May;97(5):1039-42. doi: 10.1111/j.1464-410X.2006.06132.x.
9
Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection.人组织激肽释放酶2在用于前列腺癌检测的神经网络中的临床应用
BJU Int. 2005 Sep;96(4):521-7. doi: 10.1111/j.1464-410X.2005.05677.x.
10
Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer.用于前列腺癌早期检测的各种前列腺特异性抗原比值的比较评估。
BJU Int. 2004 May;93(7):970-4; discussion 974. doi: 10.1111/j.1464-410X.2003.04762.x.

引用本文的文献

1
Comparison of survival in patients with low . intermediate prostate-specific antigen concentrations and development of a nomogram: a surveillance, epidemiology and end results program database study with external validation on a Chinese cohort.低、中度前列腺特异性抗原浓度患者的生存比较及列线图的制定:一项监测、流行病学及最终结果计划数据库研究,并在中国队列中进行外部验证
PeerJ. 2025 Aug 4;13:e19823. doi: 10.7717/peerj.19823. eCollection 2025.
2
Antibody-modified reduced graphene oxide film for circulating tumor cell detection in early-stage prostate cancer patients.用于早期前列腺癌患者循环肿瘤细胞检测的抗体修饰还原氧化石墨烯薄膜
RSC Adv. 2019 Mar 22;9(17):9379-9385. doi: 10.1039/c8ra08682f.
3
The age-specific reference intervals for tPSA, fPSA, and %fPSA in healthy Han ethnic male.
健康汉族男性中总前列腺特异性抗原(tPSA)、游离前列腺特异性抗原(fPSA)及fPSA百分比的年龄特异性参考区间。
J Clin Lab Anal. 2017 Jul;31(4). doi: 10.1002/jcla.22062. Epub 2016 Sep 20.
4
Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.基于前列腺特异性抗原的前列腺癌群体筛查:日本的现状及亚洲的未来展望
Asian J Androl. 2015 May-Jun;17(3):475-80. doi: 10.4103/1008-682X.143756.
5
Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1-10.0 ng/ml at population screening.人群筛查中总 PSA 水平为 2.1-10.0ng/ml 的男性,按游离/总 PSA 比值计算的活检前列腺癌检出的累积概率。
J Cancer Res Clin Oncol. 2014 Jan;140(1):53-9. doi: 10.1007/s00432-013-1543-9. Epub 2013 Oct 29.
6
Do the values of prostate specific antigen obtained from fresh and dried urine reflect the serum measurements?从新鲜尿液和干尿液中获得的前列腺特异性抗原值是否反映血清测量值?
Urol Ann. 2013 Apr;5(2):99-102. doi: 10.4103/0974-7796.110006.
7
Effect of heamolysis on prostate-specific antigen.溶血对前列腺特异性抗原的影响。
ISRN Urol. 2012;2012:729821. doi: 10.5402/2012/729821. Epub 2012 Dec 1.
8
Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China.前列腺癌的诊断策略与发病率:中国前列腺癌报告发病率较低的原因
Asian J Androl. 2009 Jan;11(1):9-13. doi: 10.1038/aja.2008.21. Epub 2008 Dec 1.
9
Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1-10.0 ng/ml as a criterion.游离前列腺特异性抗原(PSA)与总PSA的比值有助于提高日本人群中前列腺癌的检出率,该人群以2.1至10.0 ng/ml的PSA水平作为筛查标准。
Int J Clin Oncol. 2008 Jun;13(3):229-32. doi: 10.1007/s10147-007-0742-2. Epub 2008 Jun 14.
10
[Prostate carcinoma].[前列腺癌]
Radiologe. 2008 Jan;48(1):45-51. doi: 10.1007/s00117-007-1555-z.